Exosomes from stem cells for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had type 2 diabetes for at least 5 years but less than 20 years.
- Your most recent A1c (average blood sugar over 3 months) is between 7.5% and 9.0%.
- You are already using certain diabetes treatments, like insulin plus an oral medication or a combination of oral medications, at stable doses for at least 3 months.
- Your body makes some insulin (C-peptide level at least 1.0 ng/mL), and you do not have the antibodies that indicate Type 1 diabetes.
- Your BMI is between 18.5 and 35.
- You are willing to use effective birth control for the study period and one year after the last infusion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental stem cell treatment (DT2-SCT) to see if it can improve blood sugar control in people with type 2 diabetes who need insulin. It is a double-blind study, so neither you nor the study team will know if you get the real treatment or a placebo.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
This study tests whether exosomes (tiny particles from stem cells) can help improve blood sugar control in people with type 2 diabetes. It may offer a new way to manage the condition.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests a new type of cell therapy called cfMSC for people with type 2 diabetes. The goal is to see if it can help control blood sugar better, possibly by helping the body use insulin more effectively.
This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.